Extracts, linariin, isolinariin A and B obtained from Linaria reflexa Desf. (Scrophulariaceae) were tested for acetylcholinesterase inhibition activity using Ellman's method. A dose-response relationship was observed for all extracts and isolated compounds. Flavones exhibited IC50 values ranging from 0.27 μM to 0.30 μM. The structure-activity relationship was briefly discussed.
SelkoeDJ. (1996) Amyloid beta-protein and genetics of Alzheimer's disease. Journal of Biological Chemistry, 27, 18295–18298.
3.
LueLF, KuoYM, RoherAE. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic changes in Alzheimer's disease. American Journal of Pathology, 155, 853–862.
4.
FrancisPT, PalmerAM, SnapeM, WilcockGK. (1999) The cholinergic hypothesis of Alzheimer's disease: A review of progress. Journal of Neurology, Neurosurgery, and Psichiatry, 66, 137–147.
5.
WrightCI, GeulaC, MesulamMM. (1993) Neurological cholinesterase in the normal brain and in Alzheimer's disease: Relation to plaques, tangles, and patterns of selective vulnerability. Annals of Neurology, 34, 373–384.
6.
DaviesP, MaloneyAJ. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 2, 1457–1459.
7.
WeinstockM. (1999) Selectivity of cholinesterase inhibition: Clinical implication for the treatment of Alzheimer's Disease. CNS Drugs, 12, 303–307.
8.
RubeyRN. (2003) The cholinesterase inhibitors. Journal of Psychiatric Practice, 9, 422–430.
9.
SmallGW, RabinsPV, BarryPP, BuckholtzNS, DeKoskyST, FerrisSH, FinkelSI, GwytherLP, KhachaturianZS, LebowitzBD, McRaeTD, MorrisJC, OakleyF, SchneiderLS, StreimJE, SunderlandT, TeriLA, TuneLE. (1997) Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. Journal of the American Medical Association, 278, 1363–1371.
10.
HoughtonPJ, RenY, HowesMJ. (2006) Acetylcholinesterase inhibitors from plants and fungi. Natural Product Reports, 23, 181–199.
11.
KimHK, KimM, KimS, KimM, ChungJH. (2004) Effects of green tea polyphenol on cognitive and acetylcholinesterase activities. Bioscience, Biotechnology and Biochemistry, 68, 1977–1979.
12.
OinonenPP, JokelaJK, HatakkaAI, VuorelaPM. (2006) Linarin, a selective acetylcholinesterase inhibitor from Mentha arvensis.Fitoterapia, 77, 429–434.
ErcilD, SakarMK, Del OlmoE, San FelicianoA. (2004) Chemical constituents of Linaria aucheri.Turkish Journal of Chemistry, 28, 133–139.
15.
TundisR, DeguinB, LoizzoMR, BonesiM, StattiGA, TillequinF, MenichiniF. (2005) Potential antitumor agents: flavones and their derivatives from Linaria reflexa Desf. Bioorganic & Medicinal Chemistry Letters, 15, 4757–4760.
16.
RamassamyC. (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. European Journal of Pharmacology, 545, 51–64.
17.
RheeIK, van de MeentM, IngkaninanK, VerpoorteR. (2001) Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. Journal of Chromatography A, 915, 217–223.
18.
RheeIK, van RijnRH, VerpoorteR. (2003) Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. Phytochemical Analysis, 14, 127–131.
19.
RenY, HoughtonPJ, HiderRCH (2006) Relevant activities of extracts and constituents of animals used in traditional Chinese medicine for central nervous system effects associated with Alzheimer's disease. Journal Pharmacy and Pharmacology, 58, 989–996.
20.
HeoHJ, KimMJ, LeeJM, ChoiSJ, ChoHY, HongB, KimHK, KimE, ShinDH. (2004) Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dementia and Geriatric Cognitive Disorders, 17, 151–157.
21.
HasanA, KhanKM, SherM, MaharviGM, NawazSA, ChoudharyMI, Atta-ur-Rahman SupuranCT. (2005) Synthesis and inhibitory potential towards acetylcholinesterase, butyrylcholinesterase and lipoxygenase of some variably substituted chalcones. Journal of Enzyme Inhibition and Medicinal Chemistry, 20, 41–47.
22.
CliffordMN. (2004) Diet-derived phenols in plasma and tissues and their implications for health. Planta Medica, 70, 1103–1114.
23.
AmesBN, ShigenagaMK and HagenTM. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences USA, 90, 7915–7922.
24.
BenziG. and MorettiA. (1995) Are reactive oxygen species involved in Alzheimer's Disease?Neurobiology of Aging, 16, 661–674.
25.
Rice-EvansC. (2004) Flavonoids and isoflavones: absorption, metabolism, and bioactivity. Free Radical Biology & Medicine, 36, 827–828.
26.
YoudimKA. (2004) Flavonoids and the Brain: interactions at the Blood–Brain Barrier and their physiological effects on the central nervous system. Free Radical Biology & Medicine, 37, 1683–1693.
27.
WagnerH, BladtS. (1996) Plant Drug Analysis, Springer, Germany.
28.
PerryNS, HoughtonPJ, TheobaldA, JennerP, PerryEK. (2000) In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. Journal of Pharmacy and Pharmacology, 52, 895–902.
